The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine chemotherapy (SPIRE): Randomized expansion phase as neoadjuvant therapy for bladder urothelial carcinoma.
 
Simon J. Crabb
Honoraria - Astellas Pharma; Bayer; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BeiGene; Janssen-Cilag; Pfizer; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology
Expert Testimony - MSD
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag; MSD; MSD; Roche
 
Sarah Danson
Consulting or Advisory Role - Boehringer Ingelheim; GlaxoSmithKline; Incanthera
Research Funding - Amgen
 
James WF Catto
Honoraria - Abbott Laboratories
Consulting or Advisory Role - AstraZeneca/MedImmune; Ferring; Janssen
Speakers' Bureau - ASCO; AstraZeneca/MedImmune; MSD Oncology; Nucleix; Roche
Travel, Accommodations, Expenses - European Association of Urology
 
Syed A. Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Pierre Fabre; Roche; Sotio
Research Funding - Boehringer Ingelheim; Janssen-Cilag; Pierre Fabre
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Denise Dunkley
No Relationships to Disclose
 
Nichola Downs
No Relationships to Disclose
 
Geoff Saunders
No Relationships to Disclose
 
Michelle Light
No Relationships to Disclose
 
Naveed Sarwar
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Pfizer
 
Deborah Enting
Honoraria - AstraZeneca; Janssen; MSD; Pfizer
 
Alison Jane Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi
Speakers' Bureau - Bayer; Janssen Oncology; Pfizer
Research Funding - Genzyme
 
Amir El Ghzal
No Relationships to Disclose
 
Bernadette Johnson
No Relationships to Disclose
 
Robert A Huddart
Employment - Aspen Parkside Hopsital (I)
Leadership - Cancer clinic london Limited liability partnership
Honoraria - Janssen Oncology
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Nektar; Roche
Speakers' Bureau - MSD; Roche; Roche
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for dug discovery from Janssen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; MSD Oncology; Nektar; Roche/Genentech
 
Gareth Owen Griffiths
Honoraria - AstraZeneca
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); BionTEch (Inst); Bristol-Myers Squibb (Inst); Heartflow (Inst); Jannsenn-Cilag (Inst); Novartis (Inst); Roche (Inst)